Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

D-serine for the Schizophrenia Prodrome

The recruitment status of this study is unknown because the information has not been verified recently.
Verified June 2011 by Nathan Kline Institute for Psychiatric Research.
Recruitment status was  Active, not recruiting
Sponsor:
Collaborators:
Yale University
The Zucker Hillside Hospital
Information provided by:
Nathan Kline Institute for Psychiatric Research
ClinicalTrials.gov Identifier:
NCT00826202
First received: January 21, 2009
Last updated: October 24, 2012
Last verified: June 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: November 2012
  Estimated Primary Completion Date: November 2012 (Final data collection date for primary outcome measure)